ENvue Medical (FEED) Cash & Equivalents Growth (3y) (2017 - 2026)
ENvue Medical (FEED) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 32.23% |
| 10 | ENvue Medical | 2.52 Mn | 1.38 Mn | -266,000.00 | 62.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.42% |
| Mar 31, 2026 | 13.91% |
| Dec 31, 2025 | 15.90% |
| Sep 30, 2025 | 52.18% |
| Jun 30, 2025 | 0.97% |
| Mar 31, 2025 | -54.32% |
| Dec 31, 2024 | -54.02% |
| Sep 30, 2024 | -46.66% |
| Jun 30, 2024 | -27.40% |
| Mar 31, 2024 | -30.24% |
| Dec 31, 2023 | -24.18% |
| Sep 30, 2023 | 5.98% |
| Jun 30, 2023 | 7.79% |
| Mar 31, 2023 | 153.33% |
| Dec 31, 2022 | 26.57% |
| Sep 30, 2022 | -4.41% |
| Jun 30, 2022 | 18.49% |
| Mar 31, 2022 | 219.30% |
| Dec 31, 2021 | 105.16% |
| Mar 31, 2021 | 31.58% |